Trial Profile
Phase II trial of RVX-208 in patients with mild cognitive impairment
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2013
Price :
$35
*
At a glance
- Drugs Apabetalone (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Therapeutic Use
- 10 Apr 2013 New trial record